News

The company invested $80m in the new facility which encompasses a current Good Manufacturing Practice (cGMP) grade pilot plant and office space. The 60,000ft² facility will begin production

The multicentre, open-label study is designed to assess safety and tolerability of SOR-C13, in addition to pharmacokinetics, biomarkers and initial evidence for efficacy. Soricimed Biopharma chairman and chief

TSO is a microscopic egg of the porcine whipworm that is administered orally to regulate T-Cells and inflammatory cytokines. Coronado president and CEO Bobby W. Sandage, Jr said

According to Intellioject, Auvi-Q is the only compact auto-injector with audio and visual cues, which will guide patients and caregivers step-by-step through the injection process. Intelliject chief science

CS-TATI-1 is in preclinical development intended to target HIV TAT, which is an important target to develop new HIV drugs and also address the presentation of KSHV transactivation

The three-year, $2.5m award is a continuation to phase I SBIR grant to scan the Plasmodium falciparum proteome for protective antigens. As part of the research, ADi proteome

Atorvastatin, a generic version of Pfizer’s Lipitor, is used to lower blood cholesterol levels. In addition, Ranbaxy has received the US Food and Drug Administration approval to market

The collaboration will enable both the companies to deliver end-to-end services from initial drug discovery through to early and late phase manufacturing. Under the alliance, Molecular Profiles will

The 3K3A-APC is a form of activated human Protein C whose molecular structure has been intentionally modified to remove the undesirable side effect of bleeding. ZZ Biotech chief